External PhD candidate Erasmus School of Health Policy & Management Health Technology Assessment (HTA)
- Location
- Burg. Oudlaan 50, Rotterdam
- albuquerquedealmeida@eshpm.eur.nl
‹ Back to overview
Profile
- Fernando Albuquerque de Almeida (2021) - Economic Evaluation of Early Warning Systems for Chronic Disease Management: The Case of Heart Failure
- Fernando Albuquerque de Almeida, Isaac Corro Ramos, Maureen Rutten-van Mölken & Maiwenn Al (2021) - Modeling Early Warning Systems: Construction and Validation of a Discrete Event Simulation Model for Heart Failure - Value in Health, 24 (10), 1435-1445 - doi: 10.1016/j.jval.2021.04.004 - [link]
- Fernando Albuquerque de Almeida, Maiwenn Al, R Koymans, J Riistame, S Pauws & Hans Severens (2020) - Impact of hospitalisation on health-related quality of life in patients with chronic heart failure - Health and Quality of Life Outcomes, 18 (1) - doi: 10.1186/s12955-020-01508-8 - [link]
- NC Büyükkaramikli, Saskia de Groot, D Fayter, R Wolff, N Armstrong, L Stirk, G Worthy, Fernando Albuquerque de Almeida, J Kleijnen & Maiwenn Al (2017) - Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal - Pharmacoeconomics (Print) - doi: 10.1007/s40273-017-0581-6 - [link]